CureVac N.V. CVAC
4.66 USD 0.00 (+0.00%)
At closeJan 6, 2026, 4:00 PM EST
4.62 -0.04 -0.86%
After hours · Jan 6, 4:00 PM ET
4.57 Day range 4.66
4.00 52-week range 5.55
- YTD
- +3.10%
- 1 year
- +28.73%
News
reuters.com CureVac sues Moderna for patent infringement over COVID-19 vaccines German biotech company CureVac sued Moderna in Delaware federal court on Friday, alleging that Moderna's COVID-19 vaccine Spikevax infringed CureVac patents related to messenger RNA (mRNA)…
defenseworld.net CureVac N.V. (NASDAQ:CVAC) Given Consensus Recommendation of “Hold” by Analysts CureVac N.V. (NASDAQ: CVAC - Get Free Report) has earned a consensus rating of "Hold" from the six ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the…
benzinga.com Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why Clearwater Analytics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket 
globenewswire.com BioNTech Achieves Minimum Condition in CureVac Exchange Offer The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac's issued and outstanding shares, tendered prior to the…
seekingalpha.com CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript CureVac N.V. ( CVAC ) Shareholder/Analyst Call November 25, 2025 8:00 AM EST Company Participants Mehdi Shahidi Marco Rau Thaminda Ramanayake - Chief Business Officer & Member of Executive Board…
accessnewswire.com CureVac Announces Voting Results of Extraordinary General Meeting TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a pioneering multinational biotech company developing a new class of…
defenseworld.net Brokerages Set CureVac N.V. (NASDAQ:CVAC) PT at $6.83 CureVac N.V. (NASDAQ: CVAC - Get Free Report) has received a consensus rating of "Hold" from the six brokerages that are covering the stock, Marketbeat Ratings reports. Five research analysts have…
benzinga.com Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher 
accessnewswire.com CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an important step toward the expected closing later this year Offer…
seekingalpha.com CureVac: The Hidden Value Of The mRNA Wallet CureVac is a pioneering biotech company focused on mRNA drugs for oncology and vaccines. In biotech, value derives from research quality, patent strength, and clinical success probability, not…
accessnewswire.com CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates Entered into a definitive Purchase Agreement pursuant to which BioNTech intends to…
proactiveinvestors.co.uk GSK secures $370 million settlement and future royalties in CureVac mRNA patent dispute GSK PLC (LSE:GSK, NYSE:GSK) will receive an upfront payment of $370 million from CureVac, following a patent settlement involving BioNTech and Pfizer over messenger ribonucleic acid (mRNA) vaccine…
reuters.com CureVac settles patent dispute litigation with Pfizer and BioNTech CureVac said on Thursday that the company and GSK have entered an agreement to a resolve patent dispute with Pfizer and BioNTech related to mRNA-based COVID-19 vaccines.
accessnewswire.com CureVac Announces Voting Results of General Meeting TÜBINGEN, GERMANY AND BOSTON, MA / ACCESS Newswire / June 24, 2025 / CureVac N.V. (NASDAQ:CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on…
zacks.com CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech CVAC jumps 41% in a month after signing a $1.25B deal to be acquired by BioNTech to accelerate mRNA therapy development.
globenewswire.com $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC) NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and…
benzinga.com 5 Stocks To Ride The German Market Rally 
globenewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
investopedia.com Top Stock Movers Now: Oracle, Boeing, CureVac, and More U.S. equities were mixed and little changed at midday as another key measure of inflation, the Producer Price Index (PPI), came in lower than expected. The S&P 500 and Nasdaq advanced, while the Dow…
schaeffersresearch.com CureVac Stock Soars on BioNTech Buyout Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion.
benzinga.com BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal BioNTech SE BNTX on Thursday agreed to acquire CureVac N.V. CVAC in an all-stock transaction.
benzinga.com CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday 
proactiveinvestors.com BioNTech boosts cancer mRNA pipeline with CureVac acquisition BioNTech (NASDAQ:BNTX) announced that it is acquiring CureVac (NASDAQ:CVAC), a fellow German mRNA vaccine developer, in an all-stock deal valued at approximately $1.25 billion. Under the deal terms,…
businesswire.com CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CureVac N.V. (NASDAQ: CVAC) to BioNTech SE is fair to CureVac shareholders. Under the…
benzinga.com Earnings Scheduled For April 10, 2025 
benzinga.com Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.- benzinga.com Earnings Scheduled For November 12, 2024
benzinga.com Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
benzinga.com Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
benzinga.com Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday - benzinga.com Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
benzinga.com Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday - benzinga.com Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
- benzinga.com Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy…
- benzinga.com Earnings Scheduled For November 14, 2023 Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's session, 406 companies made new 52-week lows.
- benzinga.com Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant…
benzinga.com Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023 
benzinga.com Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
benzinga.com Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.- benzinga.com Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
- benzinga.com Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
- benzinga.com Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 325 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday OnFriday, 143 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's trading, 293 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 16, 2022 Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is estimated to report earnings for its third quarter.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.